Hyperfine (NASDAQ:HYPR) Stock Picked Up by Analysts at Lucid Cap Mkts

Lucid Cap Mkts assumed coverage on shares of Hyperfine (NASDAQ:HYPR) in a research note issued on Tuesday, Zacks reports. The firm set a “strong-buy” rating on the stock.

Several other research analysts have also weighed in on the company. BTIG Research reaffirmed a “buy” rating and issued a $2.00 target price on shares of Hyperfine in a research report on Tuesday, September 22nd. B. Riley Financial reaffirmed a “buy” rating and set a $1.60 price target (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. Loop Capital set a $2.00 price target on Hyperfine in a report on Tuesday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a research note on Thursday, October 15th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $2.02.

Hyperfine Trading Up 4.7%

NASDAQ HYPR opened at $0.78 on Tuesday. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. Hyperfine has a 1-year low of $0.70 and a 1-year high of $1.94. The firm’s fifty day simple moving average is $0.82 and its 200-day simple moving average is $1.13. The company has a market capitalization of $83.21 million, a PE ratio of -2.06 and a beta of 1.45.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.09). The firm had revenue of $3.90 million during the quarter, compared to analysts’ expectations of $4.13 million. Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. As a group, sell-side analysts anticipate that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Institutional Trading of Hyperfine

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HYPR. PFS Partners LLC lifted its holdings in shares of Hyperfine by 150.0% during the third quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock worth $40,000 after buying an additional 30,000 shares during the last quarter. Walleye Capital LLC boosted its position in shares of Hyperfine by 3.4% in the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after acquiring an additional 7,330 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of Hyperfine in the second quarter valued at approximately $419,000. Finally, Renaissance Technologies LLC grew its stake in shares of Hyperfine by 100.2% in the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after acquiring an additional 365,490 shares during the last quarter. Institutional investors and hedge funds own 15.03% of the company’s stock.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.